98 related articles for article (PubMed ID: 12438243)
1. Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism.
Yoon JH; Werneburg NW; Higuchi H; Canbay AE; Kaufmann SH; Akgul C; Edwards SW; Gores GJ
Cancer Res; 2002 Nov; 62(22):6500-5. PubMed ID: 12438243
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Leu CM; Chang C; Hu C
Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
[TBL] [Abstract][Full Text] [Related]
3. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells.
Isomoto H; Kobayashi S; Werneburg NW; Bronk SF; Guicciardi ME; Frank DA; Gores GJ
Hepatology; 2005 Dec; 42(6):1329-38. PubMed ID: 16317687
[TBL] [Abstract][Full Text] [Related]
5. The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.
Yu C; Bruzek LM; Meng XW; Gores GJ; Carter CA; Kaufmann SH; Adjei AA
Oncogene; 2005 Oct; 24(46):6861-9. PubMed ID: 16007148
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
Meng F; Yamagiwa Y; Ueno Y; Patel T
J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes.
Rao YP; Studer EJ; Stravitz RT; Gupta S; Qiao L; Dent P; Hylemon PB
Hepatology; 2002 Feb; 35(2):307-14. PubMed ID: 11826403
[TBL] [Abstract][Full Text] [Related]
8. Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c.
Wang X; Studzinski GP
Exp Cell Res; 1997 Aug; 235(1):210-7. PubMed ID: 9281370
[TBL] [Abstract][Full Text] [Related]
9. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
MacCallum DE; Melville J; Frame S; Watt K; Anderson S; Gianella-Borradori A; Lane DP; Green SR
Cancer Res; 2005 Jun; 65(12):5399-407. PubMed ID: 15958589
[TBL] [Abstract][Full Text] [Related]
10. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism.
Gao N; Kramer L; Rahmani M; Dent P; Grant S
Mol Pharmacol; 2006 Aug; 70(2):645-55. PubMed ID: 16672643
[TBL] [Abstract][Full Text] [Related]
11. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
[TBL] [Abstract][Full Text] [Related]
12. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1.
Derouet M; Thomas L; Moulding DA; Akgul C; Cross A; Moots RJ; Edwards SW
J Immunol; 2006 Jan; 176(2):957-65. PubMed ID: 16393981
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release.
Kumar P; Coltas IK; Kumar B; Chepeha DB; Bradford CR; Polverini PJ
Cancer Res; 2007 Feb; 67(3):1193-202. PubMed ID: 17283155
[TBL] [Abstract][Full Text] [Related]
14. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
Phuchareon J; McCormick F; Eisele DW; Tetsu O
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
[TBL] [Abstract][Full Text] [Related]
15. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and translational control of Mcl-1 during apoptosis.
Iglesias-Serret D; Piqué M; Gil J; Pons G; López JM
Arch Biochem Biophys; 2003 Sep; 417(2):141-52. PubMed ID: 12941295
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
[TBL] [Abstract][Full Text] [Related]
18. EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors.
Takeuchi K; Ito F
FEBS J; 2010 Jan; 277(2):316-26. PubMed ID: 19922467
[TBL] [Abstract][Full Text] [Related]
19. Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells.
Yang SH; Chien CM; Su JC; Chen YL; Chang LS; Lin SR
J Biochem Mol Toxicol; 2008; 22(6):396-404. PubMed ID: 19111001
[TBL] [Abstract][Full Text] [Related]
20. Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells.
Yang C; Kaushal V; Shah SV; Kaushal GP
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1710-7. PubMed ID: 17311906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
